알에프텍

061040KOSDAQ

69.3 / 100

Reference Date: 2026-09-08

Financial Score19.0 / 40

News Sentiment21.3 / 25

Momentum19.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 20.1% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Alphatech operates in multiple sectors, including ODM smartphone accessories, 5G base station antennas, hyaluronic acid fillers and botulinum toxin-based biopharmaceuticals, osteoarthritis treatment medical devices, display and semiconductor equipment, and lithium battery logistics automation systems. The company has expanded globally by establishing subsidiaries in China, Vietnam, the Americas, and India, and is strengthening biopharmaceutical production with the completion of a new factory in Wonju in 2024.

Number of Employees

240people

Average Salary

56.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.37Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

-14.92Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

8.04Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20250.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼5.9% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼777.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -7.7% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
알에프텍 “드론 막는 RF기술력 강화”
알에프텍이 RF 자회사 독립 출범을 통해 드론 방호 기술 분야에서의 경쟁력 강화를 선언하며 성장 전략을 구체화했다.
Positive
알에프텍, RF 전문 자회사 ‘RFTC’ 출범…5G·방산 사업 확대
알에프텍의 RFTC 자회사 출범으로 5G 및 방산 분야 사업 확장이 기대되어 긍정적 영향이 예상됩니다.

Detailed Momentum

52-week position8.0Point

Near 52w high (90%, uptrend)

Current 7,660Won52-week high 8,30052-week low 1,521

1-month return6.0Point

1m +20.06% (strong rise)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

12 totalPositive 0Neutral 12Negative 0

Neutral효력발생안내( 2026.8.14. 제출 증권신고서(합병) )2026-08-27
Neutral[기재정정]투자설명서2026-08-25
Neutral[첨부정정]증권신고서(합병)2026-08-21
Neutral[기재정정]증권신고서(합병)2026-08-21
Neutral[기재정정]투자설명서2026-08-18